Compare Navan Inc. Class A Common Stock (NAVN) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Navan Inc. Class A Common Stock vs Roivant Sciences Ltd. Common Shares — how do they compare? Navan Inc. Class A Common Stock trades at $23.63 (market cap $6.01B), while Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 4.1× Navan Inc. Class A Common Stock's market cap, and Roivant Sciences Ltd. Common Shares is more actively traded (6,279,442 versus 2,990,425). Which is the better fit depends on your goals — on Pluang, investors hold Navan Inc. Class A Common Stock for 1 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.
| NAVN | ROIV | |
|---|---|---|
Market Cap | $6.01B | $24.72B |
Volume | 2,990,425 | 6,279,442 |
Sector | Technology | Health |
52-Week High | $30.58 | $41.81 |
52-Week Low | $8.51 | $16.04 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $5.36B | $20.99B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Navan Inc. Class A Common Stock
Navan provides an AI-powered platform for business travel, payments, and expense management. Its tools support trip booking, policy controls, payment processing, expense reconciliation, and reporting.
Read more on NAVN →About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →
